FDA Adverse Event Injury Summary report: N

VALIANT

MDR report key: 4156455 · Received October 9, 2014

Report

Report Number
2953200-2014-02023
Event Type
Injury
Date Received
October 9, 2014
Date of Event
October 17, 2013
Report Date
September 18, 2014
Manufacturer
MEDTRONIC CARDIOVASCULAR
Product Code
MIH
PMA / PMN Number
P100040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

THE FOLLOWING INFORMATION WAS OBTAINED FROM A JOURNAL ARTICLE. SECONDARY AORTIC DISSECTION AFTER ENDOLUMINAL TREATMENT OF AN INTRAMURAL HEMATOMA OF THE THORACOABDOMINAL AORTA: ENDOVASCULAR EXTENSION WITH TWO STENT GRAFTS AND SCARCE DISTAL LANDING PETER I. KALMAR, PETER OBERWALDER, PETER SCHEDLBAUER, JÜRGEN STEINER, AND RUPERT H. (B)(6). THE FOLLOWING ADVERSE EVENTS WERE OBSERVED: POST-OPERATIVE DISSECTION NO FURTHER INFORMATION IS AVAILABLE FOR THIS EVENT. THE MANAGEMENT OF DISSECTIONS OF THE THORACOABDOMINAL AORTA WITH A MARGINAL DISTAL LANDING ZONE REMAINS CONTROVERSIAL. SURGICAL RECONSTRUCTION PROVIDES A SAFE WAY TO AVOID THE RISK OF VISCERAL BRANCH OCCLUSION. IN SOME CASES, HOWEVER, ENDOVASCULAR THERAPY SHOULD BE CONSIDERED WHEN A SCARCE DISTAL LANDING IS POSSIBLE. HEREIN, WE REPORT A CASE IN WHICH A THORACIC AORTIC STENT GRAFT WAS DISTALLY EXTENDED IN ORDER TO SUCCESSFULLY TREAT A SECONDARY DISSECTION CLOSE TO THE CELIAC TRUNK¿S ORIGIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
635158 VALIANT SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC CARDIOVASCULAR

Patients

Seq Age Sex Outcome Treatment
1 00051 YR Required Intervention